In the subsequent experiments, the effect of different monoamine transporter inhibitors on the [125I]MIBG uptake was compared between human platelets (uptake via SERT) and human SK-N-SH neuroblastoma cells (uptake via NET). Here, SLC6A2 is linked to neuroblastoma.